Current Trends and Characteristics of Hepatocellular Carcinoma in Patients with Autoimmune Liver Diseases
Open Access
Abstract
Hepatocellular carcinoma (HCC), the commonest among liver cancers, is one of the leading causes of mortality among malignancies worldwide. Several reports demonstrate autoimmune liver diseases (AILDs), including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC) to confer increased risk of hepatobiliary malignancies, albeit at lower frequencies compared to other liver diseases. Several parameters have been recognized as risk factors for HCC development in AIH and PBC, including demographics such as older age and male sex, clinical features, the most decisive being cirrhosis and other co-existing factors, such as alcohol consumption. Moreover, biochemical activity and treatment response have been increasingly recognized as prognostic factors for HCC development in AIH and PBC. As available treatment modalities are effective only when HCC diagnosis is established early, surveillance has been proven essential for HCC prognosis. Considering that the risk for HCC is not uniform between and within disease groups, refinement of screening strategies according to prevailing demographic, clinical, and molecular risk factors is mandated in AILDs patients, as personalized HCC risk prediction will offer significant advantage in patients at high and/or medium risk. Furthermore, future investigations should draw attention to whether modification of immunosuppression could benefit AIH patients after HCC diagnosis.Keywords
This publication has 148 references indexed in Scilit:
- Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic AcidGastroenterology, 2013
- Hepatocellular carcinoma and survival in patients with autoimmune hepatitis (Japanese National Hospital Organization‐autoimmune hepatitis prospective study)Liver International, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Immunosuppressive Cyclosporin A Activates AKT in Keratinocytes through PTEN SuppressionJournal of Biological Chemistry, 2010
- Incidence, Risk Factors, and Survival of Hepatocellular Carcinoma in Primary Biliary CirrhosisHepatology, 2009
- Risk of hepatocellular carcinoma and extrahepatic malignancies in primary biliary cirrhosisEuropean Journal of Gastroenterology & Hepatology, 2008
- Cancer immunoediting from immune surveillance to immune escapeImmunology, 2007
- Hepatocellular carcinoma and survival in patients with primary biliary cirrhosisHepatology, 2002
- International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitisJournal of Hepatology, 1999
- Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during α-interferon treatmentJournal of Hepatology, 1999